Michael Polyviou | Managing Member, EVC Group |
William Annett | President and Chief Executive Officer |
Al Parker | Chief Operating Officer |
Mitch Levine | Chief Financial Officer |
Lyndal Hesterberg | Senior Vice President, Research and Development |
Bruce Jackson | Benchmark |
Keay Nakae | Chardan |
Good day and welcome to the OncoCyte Conference Call to Discuss Second Quarter 2018 Financial Results and Operating Highlights. Today’s call is being recorded. At this time, I would like to turn the call over to Michael Polyviou of EVC Group. Please go ahead.
Thank you, Ann, and thank you everyone for joining us this afternoon’s conference call to discuss OncoCyte’s second quarter 2018 financial results and recent operating highlights.